Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1140

1.

Author response: Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Werring DJ, Merwick A, Davagnanam I, Phyu P, Bolsover F, Jichi F, Wheeler-Kingshott C, Golay X, Hughes D, Cipolotti L, Murphy E, Lachmann RH.

Neurology. 2018 Dec 4;91(23):1072. doi: 10.1212/WNL.0000000000006621. No abstract available.

PMID:
30510023
2.

Structural network disruption markers explain disability in multiple sclerosis.

Charalambous T, Tur C, Prados F, Kanber B, Chard DT, Ourselin S, Clayden JD, A M Gandini Wheeler-Kingshott C, Thompson AJ, Toosy AT.

J Neurol Neurosurg Psychiatry. 2018 Nov 22. pii: jnnp-2018-318440. doi: 10.1136/jnnp-2018-318440. [Epub ahead of print]

3.

Prominent Changes in Cerebro-Cerebellar Functional Connectivity During Continuous Cognitive Processing.

Castellazzi G, Bruno SD, Toosy AT, Casiraghi L, Palesi F, Savini G, D'Angelo E, Wheeler-Kingshott CAMG.

Front Cell Neurosci. 2018 Oct 1;12:331. doi: 10.3389/fncel.2018.00331. eCollection 2018.

4.

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis.

Castellazzi G, Debernard L, Melzer TR, Dalrymple-Alford JC, D'Angelo E, Miller DH, Gandini Wheeler-Kingshott CAM, Mason DF.

Front Neurol. 2018 Aug 20;9:690. doi: 10.3389/fneur.2018.00690. eCollection 2018.

5.

Operant Up-Conditioning of the Tibialis Anterior Motor-Evoked Potential in Multiple Sclerosis: Feasibility Case Studies.

Thompson AK, Favale BM, Velez J, Falivena P.

Neural Plast. 2018 Jul 15;2018:4725393. doi: 10.1155/2018/4725393. eCollection 2018.

6.

Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.

Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O.

Neurology. 2018 Sep 18;91(12):e1130-e1134. doi: 10.1212/WNL.0000000000006207. Epub 2018 Aug 17.

PMID:
30120132
7.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C, Eshaghi A, Altmann DR, Jenkins TM, Prados F, Grussu F, Charalambous T, Schmidt A, Ourselin S, Clayden JD, Wheeler-Kingshott CAMG, Thompson AJ, Ciccarelli O, Toosy AT.

Sci Rep. 2018 Jul 16;8(1):10715. doi: 10.1038/s41598-018-29017-1.

8.

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.

Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D, Holden D, Bianchi L, Adiutori R, MacManus D, Yousry T, Schmierer K, Turner B, Giovannoni G.

Mult Scler Relat Disord. 2018 Aug;24:123-128. doi: 10.1016/j.msard.2018.06.002. Epub 2018 Jun 28.

PMID:
29990894
9.

Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study.

Marshall I, Thrippleton MJ, Bastin ME, Mollison D, Dickie DA, Chappell FM, Semple SIK, Cooper A, Pavitt S, Giovannoni G, Wheeler-Kingshott CAMG, Solanky BS, Weir CJ, Stallard N, Hawkins C, Sharrack B, Chataway J, Connick P, Chandran S; MS-SMART Trialists.

J Neurol. 2018 Aug;265(8):1795-1802. doi: 10.1007/s00415-018-8903-y. Epub 2018 May 30.

10.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis - Authors' reply.

Thompson AJ, Reingold SC, Cohen JA; International Panel on Diagnosis of Multiple Sclerosis.

Lancet Neurol. 2018 Jun;17(6):499-500. doi: 10.1016/S1474-4422(18)30168-6. No abstract available.

PMID:
29778360
11.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

12.

Commentary on the ECTRIMS-EAN guideline for pharmacological treatment of multiple sclerosis.

Thompson AJ.

Ther Adv Neurol Disord. 2018 Apr 17;11:1756286418770378. doi: 10.1177/1756286418770378. eCollection 2018. No abstract available.

13.

Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.

Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT.

Nat Genet. 2018 May;50(5):699-707. doi: 10.1038/s41588-018-0102-3. Epub 2018 Apr 16.

14.

Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Phyu P, Merwick A, Davagnanam I, Bolsover F, Jichi F, Wheeler-Kingshott C, Golay X, Hughes D, Cipolotti L, Murphy E, Lachmann RH, Werring DJ.

Neurology. 2018 Apr 17;90(16):e1379-e1385. doi: 10.1212/WNL.0000000000005330. Epub 2018 Mar 21.

PMID:
29661900
15.

Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Cerqueira JJ, Compston DAS, Geraldes R, Rosa MM, Schmierer K, Thompson A, Tinelli M, Palace J.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):844-850. doi: 10.1136/jnnp-2017-317509. Epub 2018 Apr 4. No abstract available.

16.

Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute.

Viguera AC, Fan Y, Thompson NR, Lapin B, Chaitoff A, Griffith SD, Miller DM, Jehi L, Katzan IL.

Psychosomatics. 2018 Jul - Aug;59(4):369-378. doi: 10.1016/j.psym.2017.12.003. Epub 2017 Dec 13.

PMID:
29580558
17.

Multiple sclerosis.

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O.

Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23. Review.

PMID:
29576504
18.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):346-356. doi: 10.1002/acn3.534. eCollection 2018 Mar.

19.

Progressive neurodegeneration following spinal cord injury: Implications for clinical trials.

Ziegler G, Grabher P, Thompson A, Altmann D, Hupp M, Ashburner J, Friston K, Weiskopf N, Curt A, Freund P.

Neurology. 2018 Apr 3;90(14):e1257-e1266. doi: 10.1212/WNL.0000000000005258. Epub 2018 Mar 7.

20.

Bi-exponential 23 Na T2 * component analysis in the human brain.

Riemer F, Solanky BS, Wheeler-Kingshott CAM, Golay X.

NMR Biomed. 2018 May;31(5):e3899. doi: 10.1002/nbm.3899. Epub 2018 Feb 26.

PMID:
29480533

Supplemental Content

Loading ...
Support Center